Regulatory Know-How for Growth-Stage Life Sciences Innovators
2025-03-05 13:00 - 16:30 (America/Los_Angeles) | Torrey Heights, 11208 El Camino Real, San Diego, CA, 92130, United States
Please join Sidley’s Global Life Sciences team to lean into key early-stage and emerging growth regulatory issues, and how to tackle them.

If have questions or are interested in attending, please contact laevents@sidley.com.
Sessions will focus on:

All phases of clinical research and development
Press releases and disclosures
Regulatory wisdom from experienced emerging growth General Counsels

Connect with industry peers and investors during networking breaks and a post-program cocktail hour.
This program is designed for legal professionals and executives to provide a foundation in FDA, healthcare, and securities issues arising in development stage companies.
Featured Speakers

Himani Bhalla, Senior Managing Director, Chief Investment Officer, and Co-Founder, Symbiotic Capital
Greg Bowman, Senior Director, Leasing, Breakthrough Properties
Michael Brown, Executive Vice President and Chief, Legal Officer, DexCom, Inc.
Aneta Ferguson, Senior Vice President and General Counsel, Adverum Biotechnologies
Michael Mueller, General Counsel, Sidewinder Therapeutics, Inc.

Sidley Speakers

Torey Cope, Food, Drug, and Medical Device Regulatory
Meenakshi Datta, Healthcare: Drug and Medical Device Regulatory
Carlton Fleming, Capital Markets
Cindy Lovering, Global Finance
James Lu, Emerging Companies and Venture Capital
Jon Olsen, M&A, Emerging Companies and Venture Capital
Adam Welland, Technology and Life Sciences Transactions
Sharon Flanagan, M&A, Capital Markets, Corporate Governance

Agenda
1:00 p.m.: Registration
1:30 – 4:30 p.m.:

Clinical Research Challenges and Opportunities
Key Considerations for Press Releases and SEC Disclosures
Fireside Chat: The Importance of Regulatory Strategy and Compliance from Seasoned Emerging Growth GCs

4:30 – 6:30 p.m.: Cocktail Reception
CLE credit for this program is pending.

Boston Life Sciences Roundtable
2025-05-19 | The Institute of Contemporary Art/Boston, 25 Harbor Shore Drive, Boston, MA, 02210, United States
Join Sidley’s Life Sciences team for an afternoon of thought-provoking and engaging discussions touching on the latest trends and hot topics including the new administration, new technologies, the investment landscape, and more.

For more information, contact bosevents@sidley.com.

This year’s fifth annual event will be held in the stunning Institute of Contemporary Art/Boston lobby, followed by a reception on the picturesque harbor front plaza.
Please see below for details on our newly announced panels and panelists.
WHO SHOULD ATTEND
Executives, Investors, General Counsel, and Company Counsel
AGENDA
Registration: 1:30 p.m. ET
Program: 2:00 p.m. ET
Reception: 5:00 p.m. – 6:30 p.m. ET
FEATURED PANEL TOPICS
The New Administration, Trade Wars, and GC Strategies For Managing A Changing Environment
As the New Administration brings personnel and policy changes to HHS and FDA, and trade wars add new considerations for product development and manufacturing, we reflect on key developments and strategies GCs use to successfully manage the opportunities and risks in a changing environment.
– Lana Gladstein, General Counsel, Seaport Therapeutics
– Jose Truzman, General Counsel – U.S., Intercept Pharmaceuticals, Inc.
– Aaron Applebaum, Counsel, Global Arbitration, Trade and Advocacy
– Jackson Garvey, Partner, Restructuring & Liability Management
– Becky Wood, Partner, Global Co-leader, Food, Drug and Medical Device and Former Chief Counsel, FDA
New Product Development Pathways for Success
This panel will discuss key areas of focus during product development to set companies up for success, including the use of artificial intelligence (AI), pre-approval compliance considerations, and pricing strategies.
– Meena Datta, Partner, Global Co-leader, Healthcare
– Deeona Gaskin, Partner, Food, Drug and Medical Device and Former Associate Chief Counsel for Enforcement, FDA
Navigating Life Sciences Transactions in a Dynamic Economic Landscape
This panel will discuss the evolving landscape of life sciences transactions, including emerging trends in the current investment climate.
– Shaan Gandhi, Head of Strategic Partnerships, Pfizer Ignite
– Paresh Kumar, Vice President, Biotech Private Equity, Ally Bridge Group
– Jason Tse, Vice President Corporate Development, McKesson
– Chris York, Vice President, General Counsel & Chief of Staff, Orchard Therapeutics
– Mat Eapen, Partner, Investment Funds
KEYNOTE ADDRESS
“Get Your Mindset Right”: Thriving in Change
A Conversation with Kirk Taylor, MD on Navigating Changing Times
Kirk Taylor, MD
President & CEO
Massachusetts Life Sciences Center
Kirk Taylor, MD is a global pharmaceutical executive with expertise in Phase II – IV drug development, including CNS, oncology and rare disease. As Chief Medical Officer, Chief Strategy Officer and SVP Medical Affairs, he has restructured organizations, created strategic operating plans, and shaped corporate culture. His entrepreneurial acumen assisted in leading biotech start-up companies to successful IPOs and multiple funding rounds. He is people-first focused, leading teams with respect and innovation. In recognition of his positive impact, he was awarded the 2023 PharmaVoice 100 Executives Award.
Dr. Taylor received his Bachelor of Arts from Harvard College and studied piano at the Longy School of Music in Cambridge. He completed his Doctor of Medicine from the State University of New York, Downstate, his neurology residency at Einstein College of Medicine, and a post-doc at UCSF.

Women’s Life Sciences Network Event – Brussels
2025-05-20 17:30 - 20:00 (America/Chicago) | Comet, Place Stephanie 50, Brussels, 1050, Belgium
Join us in Brussels for our next Women’s Life Sciences Network event on the occasion of the EU Pharmaceutical Law Forum. The event will feature a moderated discussion on topical issues of pharmaceutical legislation and policy.

RSVP here.
SPEAKERS

Rainer Becker, Director, DG SANTE, European Commission
Victoria Kitcatt, Vice President and Assistant General Counsel, Head of EU/International Regulatory Law, Pfizer
Laetitia Szaller, General Counsel, Head of Compliance and ESG, Egetis Therapeutics

A Q&A session will follow the discussion.
AGENDA
5:30 p.m. – Welcome
6:00 p.m. – Panel discussion
7:00 p.m. – Networking reception and canapés
All are invited to attend WLSN events.

Good Manufacturing Practice 2025AI in Manufacturing
2025-06-03 15:45 - 17:00 (Europe/Zurich) | MA
Join us for an insightful and practical webinar on “Navigating AI Adoption in GMP-Regulated Areas While Staying Compliant.”

Webinar | RSVP here.
Key Insights:

AI in Pharma Production: Explore how AI is revolutionizing pharmaceutical production through process automation, real-time quality control, predictive maintenance, and AI-driven batch release decisions.
Regulatory Perspectives: Gain insights into how regulators in the U.S. and the EU are approaching AI in GMP-compliant manufacturing, focusing on validation, risk management, and compliance expectations.
Broader Frameworks: Understand how AI adoption fits into broader regulatory frameworks like the EU AI Act.

Featured Speakers:

Gert Thurau, Lead Technology Innovation Manufacturing, CMC Regulatory Policy, Roche
James Johnson, Partner, Sidley
Daniel J. Roberts, Senior Director, Regulatory Compliance, Sidley
Eva von Mühlenen, Senior Advisor, Sidley

Why Attend?
This session will provide a real-world discussion on how companies can effectively integrate AI into their operations while adhering to Good Manufacturing Practice (GMP) regulations.
Learn from industry and regulatory thought leaders about the latest trends and best practices in AI adoption within GMP-regulated environments.
Who Should Attend?
Executives, in-house counsel, quality and compliance managers and officers interested in and/or facing GMP compliance and quality management challenges in Switzerland.

For more information or questions, please contact gvaevents@sidley.com.
Nothing in this program may be quoted or used in any manner without the express written consent of Sidley Austin LLP. The views expressed in this program are the views of the participants, and not necessarily those of the firm. This program is for informational purposes only and should not be considered legal advice or creating an attorney-client relationship.

Bay Area Lifesciences Roundtable Navigating Uncertainty and Charting a New Course
2025-07-23 13:00 - 16:30 (America/Chicago) | SFMOMA, 147 Minna St. Floor 5, San Francisco, CA, 94103, United States
Join industry leaders, investors, and seasoned regulatory counsel for an exclusive event focused on thriving during times of change in the life sciences sector. Through dynamic panel discussions, we’ll explore the latest trends in regulation, financing, market dynamics, and federal health policy, all with a focus on how companies can continue to realize the transformative impact of new therapies and technologies. Don’t miss this opportunity to connect, learn, and chart a new course for long-term business success.
RSVP here.
AGENDA
Registration | 1:00 p.m.
Program | 1:30 p.m.
Reception 4:30 p.m.
Who may be interested in attending: Executives, Directors, Investors, and In-House Counsel
FEATURED PANELS
Regulatory Realities – Proactive Strategies in a Shifting Landscape
Explore how companies are developing new strategies to respond to the latest developments at HHS, FDA, and CMS, including major shifts in FDA leadership, staffing, and policy priorities, potential impacts on regulatory timelines and new product approvals, and new proposals related to drug pricing and reimbursement. Hear from industry insiders on how to engage effectively with regulators and adapt to new expectations in an era of uncertainty.
SPEAKERS

Anthony Davies, Ph.D., Founder & CEO, Dark Horse Consulting
Hae-Won Min Liao, Vice President, U.S. Legal Business Partner, Gilead Sciences
Emily Marden, Senior Counsel, Sidley
Catherine Starks, Partner, Sidley

Additional panelists to be announced
Financing the Future – Paths to Growth and Liquidity
Discover how investment opportunities are evolving, with a focus on financing and liquidity options including debt, royalty financing, mergers, and other strategic transactions. Leading advisors and investors will share their experience, including how shifting geopolitical and regulatory factors are shaping deals, and what it takes to secure funding and achieve liquidity in today’s market.
SPEAKERS

Ryuk Byun, Managing Director, Morgan Stanley
Hutch Corbett, Managing Partner, Armentum Partners
Carlton Fleming, Partner, Sidley
Frank Rahmani, Partner, Sidley

Additional panelists to be announced
The GLP-1 Effect – Disruption, Demand, and What’s Next for Biotech
Using GLP-1 as a case study, dive into the latest trends in product development, pricing and reimbursement, market dynamics, and federal health policy. This panel will examine issues that have arisen for the paradigm-shifting GLP-1/GIP/Gcg product category, to reveal for the future of innovation across the entire life sciences industry.
SPEAKERS

Scott Akamine, Chief Legal Officer, Kailera Therapeutics
Michael Hulka, Senior Vice President and Deputy General Counsel, Eli Lilly and Company
Torrey Cope, Partner, Sidley

Additional panelists to be announced
CLE credit for this program is pending.

For more information, contact sfevents@sidley.com.

Swiss MedTech 2025Staying Competitive in a Shifting Regulatory Landscape
2025-09-02 14:00 - 18:30 (Europe/Zurich) | Casino Bern, Casinoplatz 1, 3011, Bern, Switzerland
The Swiss MedTech industry stands at a critical crossroads: navigating rapid regulatory evolution, geopolitical shifts, and emerging technologies.

RSVP here.
For more information, please contact Geneva Events.

Join us in Bern for an interactive afternoon featuring regulators, industry leaders, legal professionals, and scientific advisors who will share practical insights, best practices, and strategic foresight.
Key highlights on the agenda include:

Regulatory Realities and Priorities
How Swiss MedTech Stays Competitive Amid Regulatory Shifts
Global Trade and Politics
U.S. Policy in 2025 – Implications for Swiss Market Access and Trade Strategy
Corporate Responsibility
From ESG to the Omnibus Act – What Swiss MedTech Must Now Comply With
New Pathway of Regulating Artificial Intelligence in Switzerland
Competitive Edge or Compliance Hurdle?

Singapore Life Sciences Roundtable
2025-09-03 09:30 - 13:00 (Asia/Singapore) | Sidley, 1501 K Street, NW Washington, D.C., 20005, United States
This intimate, industry-focused session will bring together legal and compliance professionals from multinational pharmaceutical, medtech, and biotech companies to explore how recent global developments are reshaping the regulatory and transactional landscape across Asia-Pacific.

RSVP here.

Topics include:
– The New DOJ White Collar Enforcement Playbook
What it means for APAC operations and compliance functions
– The New U.S. Administration and the FDA
Taking stock of paradigm-shifting developments in drug and device regulation
– Life Sciences Transactions in APAC
Navigating deal risks, regulatory scrutiny, and cross-border trends
PROGRAM
Registration and Refreshments: 9:30 a.m. – 10:00 a.m. SGT
Sidley Presentation and Roundtable Dialogue: 10:00 a.m. – 12:00 p.m. SGT
Networking Lunch: 12:00 p.m. – 1:00 p.m. SGT
For questions or more information, please contact asiaevents@sidley.com.

Sidley’s Medicaid Drug Rebate Program Summit Cocktail Reception
2025-09-15 18:00 - 20:00 (America/Chicago) | Avli on the Park, 180 N Field Blvd, Chicago, IL, 60601
Please join members of Sidley’s Drug Pricing Team for appetizers and cocktails – right near Chicago’s iconic Bean in Millennium Park – following Day 1 of the MDRP Summit.

RSVP here

We look forward to connecting with you!
For questions, please contact chevents@sidley.com.

Sidley Healthcare Investment Conference 2025
2025-09-30 | The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, United Kingdom
With deal and investment activity remaining critical to the success of the life sciences and healthcare industry, Sidley is bringing together senior pharma, biotech, healthcare, private equity, and venture capital leads to provide their insights on key topics, trends, and opportunities.

RSVP here.

Join Sidley and industry leaders from across the globe for this in-person, one-day event in London, with the option to stream and network virtually from outside the UK.
We look forward to incisive content, robust discussion, and valuable networking during a day of looking at the continued combination of innovation and capital driving positive patient outcomes and investment returns.
View the Sidley Healthcare Investment Conference 2024 highlights.

Women's Life Sciences NetworkGeopolitical and Trade Uncertainties: Strategies for the Life Sciences Industry
2025-10-21 17:30 - 21:00 (Europe/Zurich) | Memox, Peter-Merian Strasse 80, Basel, 4052, Switzerland
Join us in Basel for our next Women’s Life Sciences Network event, which will feature a panel discussion with leading life science industry representatives about the challenges and opportunities arising from increasingly volatile and fragmented international trade dynamics.

RSVP here.
The panel will share insights and considerations on the impact on life science companies’ operations and compliance efforts of, among others, new tariffs, retaliation measures, and other recent trade restrictions implemented in an evolving geopolitical context where countries seek to rebalance trade relations. A Q&A session will follow the moderated discussion.

All are invited to attend WLSN events.
AGENDA
5:30 p.m. – Arrival and registration
6:00 p.m. – Panel discussion and Q&A
7:30 p.m. – Networking and apéro riche
For more information, please contact brevents@sidley.com.

Biotech Dealmaking - Regulatory Considerations for the Next Wave of Development-Stage Transactions - Program and Lunch
2026-01-12 11:30 - 14:30 (America/Los_Angeles) | MA
Join members of Sidley’s Global Life Sciences team for a lunchtime CLE-accredited program during the JPM Healthcare Conference discussing the latest regulatory trends impacting the next wave of development-stage transactions.

Led by Meena Datta, global co-leader of Sidley’s Healthcare practice; Torrey Cope, partner in Sidley’s Food Drug and Medical Device (FDMD) practice; and Sally Wagner Partin, partner in Sidley’s M&A practice, this session provides keen insights on the considerations driving recent biotech dealmaking. 1 hour CLE credit available.
For questions, please contact sfevents@sidley.com.

Connecting Clusters of Excellence: Europe as Your Gateway to Global Success
2026-01-12 13:30 - 17:30 (America/Los_Angeles) | The Town Hall, 555 California Street, San Francisco, CA, 94104, United States
Join Sidley, Biovia, Health Campus Limburg DC, and others for an engaging afternoon exploring collaborative growth opportunities across the global life sciences landscape.

RSVP here.
The event will feature two dynamic panel discussions, with the latter being moderated by Sidley’s Becky Wood, global co-leader of Sidley’s FDA practice and former Chief Counsel at FDA.
Panel 1: Europe Recharged: Innovation Thrives Here. We Are Ready for the Global Stage.
Europe’s biotech and healthtech ecosystems are accelerating. With strong public-private partnerships, world-class research, and coordinated investment strategies, Europe is no longer catching up, it’s setting the pace. Discover how clusters across the continent are shaping global markets through collaboration and scale.
Panel 2: Redefining Women’s Health: Europe and the U.S. Unite to Power Innovation, Investment, and Impact.
A new wave of investors and innovators is turning women’s health into one of the fastest-growing markets in healthcare. How can we ensure women’s health is not just a “hot topic,” but an enduring pillar of innovation and research? This panel brings together U.S. and European leaders driving science, technology, and capital toward an overdue revolution in women’s health, from overlooked needs to global opportunities.
This gathering brings together leaders, innovators, and ecosystem builders to spark meaningful dialogue and foster new pathways for international collaboration.
Please note that delegate contact details may be passed between Sidley Austin LLP, Biovia, and Health Campus Limburg DC for the purposes of organizing and administering these events, and for contacting you about these events. The organizers are using third party websites, not controlled by Sidley, and your personal information will be processed in accordance with the Eventbrite Privacy Policy. For information on Sidley’s use of your personal information please refer to our Privacy Policy and for questions about these events please contact sfevents@sidley.com.

At the Table: Serving Up a Lively Discussion With the FDA and USDA
2026-01-28 09:30 - 16:30 (America/New_York) | Sidley, 1501 K Street, NW Washington, D.C., 20005, United States
Please join Sidley’s Food, Drug, and Medical Device team for a Meet the Regulators Roundtable which will include: Stephen A. Vaden, USDA Deputy Secretary; Tyler Clarkson, USDA General Counsel; Kyle Diamantas, FDA Deputy Commissioner for Human Foods, and Sean Keveney, FDA Chief Counsel.

For registration information, please contact dcevents@sidley.com.

Agenda
Registration | 9:30 a.m. ET
Panels | 10:00 a.m. – 12:10 p.m. ET
Lunch | 12:15 p.m. – 1:15 p.m. ET
Meet the Regulators Roundtable | 1:30 p.m. – 3:00 p.m. ET
Cocktail Reception | 3:00 p.m. – 4:30 p.m. ET
The event will bring together industry leaders for a lively discussion on regulatory compliance, enforcement actions, litigation, and related issues facing the food industry.
Panel discussions prior to the Regulator Roundtable will include:
– The Changing Landscape in Washington Food Regulation
– Enforcement and Litigation – Risks, Opportunities, and Trends
CLE credit is pending for this program. Sidley Austin LLP is an Approved Accredited Provider of CA, IL, and NY CLE credit.

Life Sciences College 2026
2026-02-12 08:30 - 17:00 (Europe/Brussels) | Renaissance Brussels Hotel, Rue du Parnasse 19, Brussels, 1000, Belgium
Join EUCOPE and Sidley for the annual Life Sciences College (LSC) for an exclusive, full-day forum on the future of life sciences in Europe.

RSVP here.
Get ready for a high-impact day of insight and connection at LSC, where life sciences leaders gather to explore the legal, regulatory, and policy shifts shaping the industry.
Why Attend?

– Connect with key decision-makers from the European Commission, regulatory bodies, industry, and the investment community
– Hear exclusive insights on legal, policy, and regulatory trends shaping the EU life sciences landscape
– Join strategic discussions on emerging challenges and opportunities across the sector
– Network with leaders from pharma, biotech, medtech, and venture capital
Who Should Attend
In-house counsel, regulators, and regulatory personnel.There is no registration fee to attend this event.
For more information, contact brevents@sidley.com.

Sidley Sponsors the 2026 EU Pharma Law Forum
2026-05-19 - 2026-05-21 | Steigenberger Icon Wiltcher’s, Brussels
Sidley is proud to sponsor and participate in the EU Pharma Law Forum, the leading annual gathering of regulators, in-house counsel, policymakers, and industry stakeholders shaping the future of European pharmaceutical law.
View agenda here.
Sidley partner Anne Robert will be speaking on “How to Respond to Dawn Raids and Investigations.” Josefine Sommer will present on “Early Experiences from the HTA Regulation: Market Access Pricing and Reimbursement.”
We look forward to connecting with clients, colleagues, and industry leaders in Brussels to discuss the evolving legal landscape and the strategic considerations facing the pharmaceutical sector in 2026 and beyond.

Women’s Life Sciences Network – Biotech Act: Funding and Investment Opportunities
2026-05-19 17:30 - 21:00 (Europe/Brussels) | Comet, Place Stephanie 50, Brussels, 1050, Belgium
Join us in Brussels for our next Women’s Life Sciences Network event on the occasion of the EU Pharmaceutical Law Forum.

RSVP here.

Our speakers will discuss the proposed Biotech Act I, focusing on funding and regulatory support opportunities for the European biopharmaceutical industry.
Join our moderated panel discussion with:
Felicitas Riedl, Director of Innovation and Competitiveness Department, European Investment Bank
Alexandra Eftimie, Legal and Policy Officer, European Commission
Kristin Thompson, Director, Merieux Equity Partner
Valerie Vanhooren, CEO & Co-founder, Ona Therapeutics
The event will include a video address by Stine Bosse, MEP for the Renew Europe group and Vice Chair of the Committee on Public Health in the European Parliament.
Agenda
Welcome and registration – 5:30 p.m. CEST
Panel discussion and Q&A – 6:00 p.m. CEST
Networking reception and canapés – 7:30 p.m. CEST
Stay tuned for more details. All are invited to attend WLSN events.

Boston Life Sciences RoundtableThe New Playbook: Financing, Dealmaking, and Regulation in a Rewired Environment
2026-06-09 13:30 - 18:30 (America/Chicago) | Alexandria Center for Life Science® – Fenway Megacampus™, 201 Brookline Ave, Boston, MA, 02215, United States
Join Sidley’s Life Sciences team for an afternoon of thought-provoking and engaging discussions touching on the latest trends and hot topics including the current administration, emerging technologies, the investment landscape, and more.
Agenda
Registration: 1:30 p.m. ET
Program: 2:00 p.m. ET
Reception: 5:00 p.m. – 6:30 p.m. ET
Who Should Attend?
Executives, Investors, General Counsel, and Company Counsel

For more information, contact bosevents@sidley.com.

Bay Area Life Sciences Roundtable
2026-07-22 13:00 - 16:30 (America/Los_Angeles) | SFMOMA, 147 Minna St. Floor 5, San Francisco, CA, 94103, United States
Please join Sidley at SFMOMA for our annual Bay Area Life Sciences Roundtable, an afternoon of thoughtful and engaging discussions addressing cutting-edge trends and hot topics.

By Invitation Only. Space is limited. For questions, please contact sfevents@sidley.com.
Who may be interested in attending:
Executives, Directors, Investors, and In-House Counsel
CLE credit for this program is pending.
